Remove Protein Expression Remove Research Remove Research Laboratories
article thumbnail

Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors - A Preview of Strateos’ Presentation at SynBioBeta 2021

The Strateos Blog: Drug Discovery

Learn how Strateos’ automated synthetic biology modules supported rapid, iterative screening of RNA sequences in modular pbuE expression system and E. coli extract-based cell-free protein expression assays.

article thumbnail

Informed Design of Bioanalytical PCR Assay Testing Parameters

PPD

These treatments use a vector to introduce the desired nucleic acid code to replace or modify protein expression or use cells to alter/restore a specific cell type. Emerging areas of pharmaceutical research not only bring novel opportunities but also new regulatory guidance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Biology Can Learn from Physics

Codon

As money poured into wartime research programs, physics shifted from a field of brilliant individuals to one of well-managed teams. Biology has had a few large-scale research programs, such as the Human Genome Project , but nowhere near the same number as physics. For one, biology research is inherently broad.

article thumbnail

What Biology Can Learn from Physics

Codon

As money poured into wartime research programs, physics shifted from a field of brilliant individuals to one of well-managed teams. Biology has had a few large-scale research programs, such as the Human Genome Project , but nowhere near the same number as physics. For one, biology research is inherently broad.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Novel platforms This session will begin with chariperson’s remarks from Lars Linden, PhD, Vice President, Head, Biologics Research, Bayer HealthCare, which will be followed by a keynote presentation by Agnieszka Kielczewska, PhD, Director, Research, Antibody Discovery and Screening, Biologics Discovery, Amgen.